Home

Christopher L Gaenzle

CIK 1624044 · EVP, CAO & General Counsel · last filed 2021-07-01

Christopher L Gaenzle is an EVP, CAO & General Counsel who has filed 27 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for PRAH, was dated Jul 1, 2021. Across all open-market trades the lifetime net is −$18.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $58.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$58.5K

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$18.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRA Health Sciences, Inc. (PRAH) Delisted EVP, CAO & General Counsel 0 $165.21 $0 -$10.16M 7 2021-07-01
Syneos Health, Inc. (SYNH) Delisted CAO, GC & Sec 52,722 $42.98 $2.27M -$60.3K 2 2018-01-30
INCR CAO, GC & Sec 60,579 $0.97 $58.5K -$7.85M 18 2017-09-19

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-01 PRA Health Sciences, Inc. (PRAH) Delisted Disp (D) −34,500 $0 EDGAR
2021-06-21 PRA Health Sciences, Inc. (PRAH) Delisted Mixed — -$1.86M EDGAR
2021-06-17 PRA Health Sciences, Inc. (PRAH) Delisted Mixed −1,973 -$2.12M EDGAR
2021-06-03 PRA Health Sciences, Inc. (PRAH) Delisted Mixed +1,973 -$144.9K EDGAR
2021-01-11 PRA Health Sciences, Inc. (PRAH) Delisted Sell (S) −3,136 -$407.8K EDGAR
2020-08-17 PRA Health Sciences, Inc. (PRAH) Delisted Sell (S) −1,364 -$140.3K EDGAR
2020-06-03 PRA Health Sciences, Inc. (PRAH) Delisted Grant (A) — $0 EDGAR
2018-01-30 Syneos Health, Inc. (SYNH) Delisted Tax (F) −912 -$37.2K EDGAR
2018-01-23 Syneos Health, Inc. (SYNH) Delisted Mixed −2,263 -$92.7K EDGAR
2017-09-19 INCR Mixed −8,927 -$488.3K EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.